News

Pharmabiz20m

PCI Biotech discontinues development of PCL technology and evaluation of future operations

PCI Biotech discontinues development of PCL technology and evaluation of future operations: Oslo, Norway Wednesday, August 20, 2025, 14:00 Hrs [IST] PCI Biotech Holding ASA, a bio ...
Pharmabiz1h

MedImpact offers low cost, unbranded ustekinumab-aekn biosimilar

MedImpact offers low cost, unbranded ustekinumab-aekn biosimilar: San Diego, California Wednesday, August 20, 2025, 13:00 Hrs [IST] MedImpact Holdings Inc., the largest independen ...
Pharmabiz2h

Lupin launches bosentan tablets for oral suspension in US with 180-day exclusivity

Lupin launches bosentan tablets for oral suspension in US with 180-day exclusivity: Our Bureau, Mumbai Wednesday, August 20, 2025, 12:20 Hrs [IST] Global pharma major Lupin Limite ...
Pharmabiz2h

Viking Therapeutics reports positive top-line results from phase 2 VENTURE-Oral Dosing trial of VK2735 tablet formulation in patients with obesity

Viking Therapeutics reports positive top-line results from phase 2 VENTURE-Oral Dosing trial of VK2735 tablet formulation in patients with obesity: San Diego Wednesday, August 20, ...
Pharmabiz3h

RemeGen and Santen ink exclusive licensing agreement for ophthalmic innovative drug RC28-E in Greater China and Asian countries

RemeGen and Santen ink exclusive licensing agreement for ophthalmic innovative drug RC28-E in Greater China and Asian countries: Yantai, China Wednesday, August 20, 2025, 11:00 Hr ...
Pharmabiz4h

Boehringer Ingelheim & Palatin Technologies ink global research collaboration and licensing pact to develop innovative therapy for retinal diseases

Boehringer Ingelheim & Palatin Technologies ink global research collaboration and licensing pact to develop innovative therapy for retinal diseases: Ingelheim, Germany Wednesday, ...
Pharmabiz5h

Health Canada approves Iovance’s Amtagvi for the treatment of advanced melanoma

Health Canada approves Iovance’s Amtagvi for the treatment of advanced melanoma: San Carlos, California Wednesday, August 20, 2025, 09:00 Hrs [IST] Iovance Biotherapeutics, Inc.
Pharmabiz6h

MTaI recommends limiting refurbishment of medical devices to OEMs

MTaI recommends limiting refurbishment of medical devices to OEMs: Our Bureau, New Delhi Wednesday, August 20, 2025, 08:00 ...
Pharmabiz6h

DoC begins stakeholder consultations with Pharmexcil & industry on trade negotiations with Peru & Chile

DoC begins stakeholder consultations with Pharmexcil & industry on trade negotiations with Peru & Chile: Shardul Nautiyal, Mumbai Wednesday, August 20, 2025, 08:00 Hrs [IST] The U ...
Pharmabiz6h

Natureoroma to roll out Squacare topical oral gel for oral submucous fibrosis patients

Natureoroma to roll out Squacare topical oral gel for oral submucous fibrosis patients: Nandita Vijayasimha, Bengaluru Wednesday, August 20, 2025, 08:00 Hrs [IST] Natureoroma in R ...
Pharmabiz6h

AKCDA Kollam to protest against social media advertising by discount pharmacies

AKCDA Kollam to protest against social media advertising by discount pharmacies: Peethaambaran Kunnathoor, Chennai Wednesday, August 20, 2025, 08:00 Hrs [IST] A new controversy is ...
Pharmabiz6h

MIT College of Pharmacy, Mandya highlights mismatch of Pharm D training and job opportunities

MIT College of Pharmacy, Mandya highlights mismatch of Pharm D training and job opportunities: Nandita Vijayasimha, Bengaluru Wednesday, August 20, 2025, 08:00 Hrs [IST] There is ...